Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-17

Clinical Trial Update: A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing safety and equivalence of generic azelaic acid foam to Finacea foam in rosacea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelaic acid foam (generic) (azelaic acid)
  • FINACEA FOAM (AZELAIC ACID)

Snippet

Sponsor: Actavis Inc. | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2019-07-17